ACCESS Consortium: Points to consider for strain changes in authorised COVID-19 vaccines in an ongoing SARS-CoV2 pandemic
This Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-06-30
Data overview
- Formats
- HTML
- File languages
- English, French